Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John A. Kessler, MD
Northwestern University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Research Center
Phoenix, Arizona, United States
- Clinical Trials, Inc.
Little Rock, Arkansas, United States
- Northern California Research
Sacramento, California, United States
- Center for Clinical Research
San Francisco, California, United States
- Neurological Research Institute
Santa Monica, California, United States
- Diablo Clinical Research, Inc.
Walnut Creek, California, United States
- Innovative Research of West Florida
Clearwater, Florida, United States
- University of Florida Mcknight Brain Institute
Gainesville, Florida, United States
- Clinical Research of West Florida
Tampa, Florida, United States
- the Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Raleigh Neurology Associates, P.A.
Raleigh, North Carolina, United States
- Nerve and Muscle Center of Texas
Houston, Texas, United States
- Evms (eastern Virginia Medical School)
Norfolk, Virginia, United States
- Rainier Clinical Research Center, Inc.
Renton, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Feb 2019
- Primary completion
- 24 Jul 2019
- Completion
- 24 Jul 2019
- Last update posted
- 9 Oct 2025
- Registered enrollment
- 101
- Registry id
- NCT04055090
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.